Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Abstract

SummaryBackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from 1990 to 2017. Previous GBD studies have shown how the decline of mortality rates from 1990 to 2016 has led to an increase in life expectancy, an ageing global population, and an expansion of the non-fatal burden of disease and injury. These studies have also shown how a substantial portion of the world's population experiences non-fatal health loss with considerable heterogeneity among different causes, locations, ages, and sexes. Ongoing objectives of the GBD study include increasing the level of estimation detail, improving analytical strategies, and increasing the amount of high-quality data.MethodsWe estimated incidence and prevalence for 354 diseases and injuries and 3484 sequelae. We used an updated and extensive body of literature studies, survey data, surveillance data, inpatient admission records, outpatient visit records, and health insurance claims, and additionally used results from cause of death models to inform estimates using a total of 68 781 data sources. Newly available clinical data from India, Iran, Japan, Jordan, Nepal, China, Brazil, Norway, and Italy were incorporated, as well as updated claims data from the USA and new claims data from Taiwan (province of China) and Singapore. We used DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of estimation, ensuring consistency between rates of incidence, prevalence, remission, and cause of death for each condition. YLDs were estimated as the product of a prevalence estimate and a disability weight for health states of each mutually exclusive sequela, adjusted for comorbidity. We updated the Socio-demographic Index (SDI), a summary development indicator of income per capita, years of schooling, and total fertility rate. Additionally, we calculated differences between male and female YLDs to identify divergent trends across sexes. GBD 2017 complies with the Guidelines for Accurate and Transparent Health Estimates Reporting.FindingsGlobally, for females, the causes with the greatest age-standardised prevalence were oral disorders, headache disorders, and haemoglobinopathies and haemolytic anaemias in both 1990 and 2017. For males, the causes with the greatest age-standardised prevalence were oral disorders, headache disorders, and tuberculosis including latent tuberculosis infection in both 1990 and 2017. In terms of YLDs, low back pain, headache disorders, and dietary iron deficiency were the leading Level 3 causes of YLD counts in 1990, whereas low back pain, headache disorders, and depressive disorders were the leading causes in 2017 for both sexes combined. All-cause age-standardised YLD rates decreased by 3·9% (95% uncertainty interval [UI] 3·1–4·6) from 1990 to 2017; however, the all-age YLD rate increased by 7·2% (6·0–8·4) while the total sum of global YLDs increased from 562 mil...

Molecular epidemiology of group A rotavirus in outpatient diarrhea infants and children in Chongqing, China, 2011‐2015

“…Diarrhea is the second leading cause of mortality in infant and young children under 5 years old worldwide, with rotaviruses as the leading pathogen, causing an estimated 199 000 (165, 000‐241, 000) annual deaths among children <5 years of age . There is no specific drug for the rotavirus diarrhea, but safe, effective, and affordable vaccination is an effective means to prevent and control rotavirus infection .…”

Socio‐economic disparity in global burden of near vision loss: an analysis for 2017 with time trends since 1990

“…As a newly introduced concept but the leading cause of blindness and vision impairment in the Global Burden of Diseases (GBD) 2017 study, near vision loss is defined as individuals have difficulty with seeing things that are nearer than three feet, but have no difficulty with seeing things at a distance (James et al. ; Kyu et al. ).…”

Congenital heart disease in low‐and‐middle‐income countries: Focus on sub‐Saharan Africa

“…The 2017 Global Burden of Disease study from https://vizhub.healthdata.org/gbd-compare/ utilizes published literature, survey data, and administrative records (health encounters, registries, and disease surveillance systems) to estimate fatal and nonfatal data including prevalence and disability‐adjusted life years (DALYs) (James, Abate, Abate, & GBD‐Collaborators, ). Figure a and b show all‐age and age‐standardized global prevalence rates of CHD, respectively.…”